Edwards Lifesciences to Webcast Analyst Meeting at TCT 25

Marketwired

IRVINE, CA--(Marketwired - Oct 28, 2013) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, will be hosting a meeting for securities analyst attending the Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium. The meeting will be held at the InterContinental San Francisco Hotel in San Francisco, California on Thursday, October 31, 2013 from 7:00 a.m. to 8:00 a.m. PT.

A live webcast will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com. Following the presentation, an archived version of the webcast will be available on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.

Contact:
Media
Sarah Huoh
949-250-5070

Investor
David K. Erickson
949-250-6826

Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA USA 92614
Phone: 949.250.2500
Fax: 949.250.2525
www.edwards.com
View Comments (0)